Position in ANIK
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$47,023
+$30,485 QoQ
Shares Held
3,243
+88.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $291,116,040 across 50 Drug Manufacturers - Specialty & Generic names. ANIK ranks #39 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
578,753 | $68,414,382 | |
| 2 | VTRS |
Viatris Inc
|
3,347,591 | $45,225,949 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
67,551 | $40,056,384 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
219,755 | $28,950,515 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
645,037 | $15,435,730 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
393,588 | $11,854,866 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
193,436 | $10,698,942 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
138,941 | $10,684,560 |
All Filings in ANIK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,023 | 3,243 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $16,538 | 1,721 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $18,799 | 2,000 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,617 | 531 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $6,553 | 436 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,460 | 271 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,174 | 169 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,798 | 71 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $1,168 | 46 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $770 | 34 | Shares | Defined | 2024-02-05 | |
| 2023-06-30 | $15,639 | 602 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $18,840 | 656 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,571,587 | 86,878 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $2,316,715 | 97,341 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $2,340,050 | 104,841 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $2,552,203 | 101,641 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $3,850,433 | 107,464 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $5,038,932 | 118,396 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $6,097,006 | 140,841 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $10,327,577 | 253,189 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $9,344,424 | 206,461 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $4,962,562 | 140,225 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $4,097,401 | 108,598 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,698,577 | 58,754 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||